Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study.
Ivashchenko AA, Morozova MA, Vostokova NV, Beniashvily AG, Bukhanovskaya OA, Burminskiy DS, Egorova AN, Gluskina LY, Gorchakov DS, Karapetian RN, Kasimova LN, Kravchenko DV, Lepilkina TA, Merkulova EA, Mitkin OD, Penchul NA, Potanin SS, Rupchev GE, Ivachtchenko AV. Ivashchenko AA, et al. Among authors: potanin ss. J Psychiatr Res. 2021 Nov;143:436-444. doi: 10.1016/j.jpsychires.2021.10.008. Epub 2021 Oct 11. J Psychiatr Res. 2021. PMID: 34656876 Clinical Trial.
5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial).
Morozova M, Burminskiy D, Rupchev G, Lepilkina T, Potanin S, Beniashvili A, Lavrovsky Y, Vostokova N, Ivaschenko A. Morozova M, et al. J Clin Psychopharmacol. 2017 Apr;37(2):169-175. doi: 10.1097/JCP.0000000000000673. J Clin Psychopharmacol. 2017. PMID: 28141622 Clinical Trial.
[An effect of cholinesterase blockade on negative symptoms in schizophrenia].
Morozova MA, Potanin SS, Rupchev GE, Burminskiy DS, Lepilkina TA, Beniashvili AG. Morozova MA, et al. Among authors: potanin ss. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(8):37-44. doi: 10.17116/jnevro202112108137. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34481434 Russian.
Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study.
Morozova MA, Lepilkina TA, Rupchev GE, Beniashvily AG, Burminskiy DS, Potanin SS, Bondarenko EV, Kazey VI, Lavrovsky Y, Ivachtchenko AV. Morozova MA, et al. Among authors: potanin ss. CNS Spectr. 2014 Aug;19(4):316-23. doi: 10.1017/S1092852913000394. Epub 2013 Jun 17. CNS Spectr. 2014. PMID: 23768250 Clinical Trial.
[Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission].
Morozova MA, Potanin SS, Burminskiy DS, Beniashvili AG, Rupchev GE, Lepilkina TA, Sorokin MY, Kasyanov ED, Mazo GE, Tarumov DA, Trufanov AG, Markin KV, Beybalaeva TZ, Katok AA, Tsapko DS. Morozova MA, et al. Among authors: potanin ss. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(8):120-127. doi: 10.17116/jnevro2022122081120. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 36036413 Russian.
[The use of acatinol in the treatment of stable patients with schizophrenia with predominance of behaviour disorganization and subcatatonic features].
Morozova MA, Rupchev GE, Kozhekin IG, Arsenieva TB, Cheremin RA, Yachmenev VN, Onegina EY, Shvedova AK, Beniashvili AG, Burminsky DS, Lepilkina TA, Potanin SS. Morozova MA, et al. Among authors: potanin ss. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(1):35-41. Zh Nevrol Psikhiatr Im S S Korsakova. 2014. PMID: 24637815 Clinical Trial. Russian.
12 results